Skip to main content
SpringerLink
Log in

Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors

  • Articles
  • Etoposide and Teniposide in vitro
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

In order to determine if any inherent sensitivity differences may exist between VP16-213 and VM26 individual human tumors were grown in vitro and drug sensitivities were determined using the soft agar clonogenic assay method. Only nine of the 34 tumors tested so far showed a differing sensitivity to VP16-213 and VM26 as measured by a 25% or greater colony number reduction. However in none of these tumors did this added reduction result in a 70% decrease over control plate colony numbers. As yet we have been unable to demonstrate any clinically meaningful inherent in vitro sensitivity difference between VP16-213 and VM26 in any tumor type tested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alberts DS, Chen HSG, Soehnlen B, Salmon SE, Surwit EA, Young L, Moon TE (1980) In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet 2:340–342

    Google Scholar 

  2. Allen LM, Creaven PJ (1975) Comparison of the human pharmacokinetics of VM26 and VP16-213, two antineoplastic epipodophyllotoxin glucopyranoside derivatives. Eur J Cancer 11:697–707

    Google Scholar 

  3. Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197:461–463

    Google Scholar 

  4. Hamburger AW, Salmon SE, Kim MB, Trent JM, Soehnlen BJ, Alberts DS, Schmidt HJ (1978) Direct cloning of human ovarian carcinoma cells in agar. Cancer Res 38:3438–3444

    Google Scholar 

  5. Issell BF, Crooke ST (1979) Etoposide. Cancer Treat Rev 6:107–124

    Google Scholar 

  6. Salmon SE, Hamburger SW, Soehnlen B, Durie BGM, Alberts DS, Moon TE (1978) Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 298:1321–1327

    Google Scholar 

  7. VonHoff DD (1980) Clinical correlations of drug sensitivity in tumor stem cell assay. Proc AACR 21:134

    Google Scholar 

  8. VonHoff DD, Casper J, Bradley E, Sandbach J, Jones D, Makuch R (1981) Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 70:1027–1032

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bristol Laboratories, P.O. Box 657, 13201, Syracuse, NY, USA

    Brian F. Issell, Claude Tihon & M. Elaine Curry

  2. Upstate Medical Center, 750 Adams Street, 13201, Syracuse, NY, USA

    Brian F. Issell & Claude Tihon

Authors
  1. Brian F. Issell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claude Tihon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Elaine Curry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Issell, B.F., Tihon, C. & Curry, M.E. Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors. Cancer Chemother. Pharmacol. 7, 113–115 (1982). https://doi.org/10.1007/BF00254531

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254531

Keywords

Search

Navigation